{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:55:09Z","timestamp":1793667309455,"version":"4.5.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-019201 and MJFF-025704"],"award-info":[{"award-number":["MJFF-019201 and MJFF-025704"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Preclinical evidence suggests positive symptomatic and neuroprotective effects of hypoxic conditioning in Parkinson\u2019s disease (PD). This study (NCT05214287) investigated the safety, feasibility, short-term symptomatic and downstream effects of hypoxic conditioning in individuals with PD. 20 individuals with PD (mean age 62, 10 women, Hoehn-Yahr 1.5-3) completed randomized controlled double-blinded multiple N-of-1 trials. Each participant underwent five different 45-minute hypoxia interventions in duplicate: continuous hypoxia at FiO\n                    <jats:sub>2<\/jats:sub>\n                    0.163 and 0.127, intermittent (five-minute intervals interspersed with normoxia) at FiO\n                    <jats:sub>2<\/jats:sub>\n                    0.163 and 0.127, and placebo. Primary outcomes were safety and feasibility as measured by adverse events, vital parameter disturbances, participant-rated discomfort and feasibility questionnaires. Secondary outcomes were short-term participant-rated and assessor-rated symptom scores. Exploratory indicators of target engagement were serum erythropoietin, brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), neurofilament light-chain (NfL), platelet-derived growth factor-receptor-\u03b2 (PDGFR\u03b2) and cortisol. Secondary outcomes were evaluated using frequentist and Bayesian analysis. 20 participants completed the protocol. The trial met its primary endpoints for safety and feasibility. 95 adverse events occurred, including one moderate and three serious events. Adverse events were not dose-dependent and occurred at comparable incidence following hypoxia and placebo. Hypoxic conditioning was well-tolerated. Low-F\n                    <jats:sub>I<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    protocols caused significant oxygen desaturations in two participants. Participants considered longer-term application feasible. Intermittent hypoxia at F\n                    <jats:sub>I<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    0.163 modestly improved most participant-rated symptoms for several hours compared to placebo, but not assessor-rated scales. One hour after intervention, serum markers did not differ between interventions. Hypoxic conditioning is safe and feasible in individuals with PD, and specific protocols may be associated with short-term symptom improvement. These findings inform and support follow-up studies of longer-term safety and efficacy of hypoxic conditioning.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-63324-2","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:06:11Z","timestamp":1758888371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hypoxic conditioning in Parkinson\u2019s disease: randomized controlled multiple N-of-1 trials"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-5882","authenticated-orcid":false,"given":"Jules M.","family":"Janssen Daalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-7035","authenticated-orcid":false,"given":"Marjan J.","family":"Meinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-0940","authenticated-orcid":false,"given":"Federica","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6224-7573","authenticated-orcid":false,"given":"Soania","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick H. J.","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-3337","authenticated-orcid":false,"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"63324_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF00999391","volume":"4","author":"PA Broderick","year":"1989","unstructured":"Broderick, P. A. & Gibson, G. E. Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxia. Metab. Brain Dis. 4, 143\u2013153 (1989).","journal-title":"Metab. Brain Dis."},{"key":"63324_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fnins.2020.00869","volume":"14","author":"AS Barath","year":"2020","unstructured":"Barath, A. S. et al. Hypoxia-associated changes in striatal tonic dopamine release: real-time in vivo measurements with a novel voltammetry technique. Front. Neurosci. 14, 869 (2020).","journal-title":"Front. Neurosci."},{"key":"63324_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.neuint.2005.02.005","volume":"46","author":"C Orset","year":"2005","unstructured":"Orset, C. et al. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem. Int. 46, 623\u2013633 (2005).","journal-title":"Neurochem. Int."},{"key":"63324_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1471-4159.1991.tb08249.x","volume":"57","author":"Y Akiyama","year":"1991","unstructured":"Akiyama, Y. et al. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis. J. Neurochem. 57, 997\u20131002 (1991).","journal-title":"J. Neurochem."},{"key":"63324_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/jnr.21988","volume":"87","author":"L Witten","year":"2009","unstructured":"Witten, L. et al. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo. J. Neurosci. Res. 87, 1686\u20131694 (2009).","journal-title":"J. Neurosci. Res."},{"key":"63324_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1471-4159.2010.06917.x","volume":"115","author":"JL Johansen","year":"2010","unstructured":"Johansen, J. L. et al. HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells. J. Neurochem. 115, 209\u2013219 (2010).","journal-title":"J. Neurochem."},{"key":"63324_CR7","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1074\/jbc.M407706200","volume":"280","author":"G Yuan","year":"2005","unstructured":"Yuan, G., Nanduri, J., Bhasker, C. R., Semenza, G. L. & Prabhakar, N. R. Ca2+\/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J. Biol. Chem. 280, 4321\u20134328 (2005).","journal-title":"J. Biol. Chem."},{"key":"63324_CR8","doi-asserted-by":"crossref","unstructured":"Belikova, M. V., Kolesnikova, E. E. & Serebrovskaya, T. V. Intermittent hypoxia and experimental Parkinson\u2019s disease. In Intermittent hypoxia and human diseases (eds. Xi, L. & Serebrovskaya, T.) 147\u2013153 (Springer, 2012).","DOI":"10.1007\/978-1-4471-2906-6_12"},{"key":"63324_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1365-201X.1998.00335.x","volume":"162","author":"M Rostrup","year":"1998","unstructured":"Rostrup, M. Catecholamines, hypoxia and high altitude. Acta Physiol. Scand. 162, 389\u2013399 (1998).","journal-title":"Acta Physiol. Scand."},{"key":"63324_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1471-4159.2003.01696.x","volume":"85","author":"PO Schnell","year":"2003","unstructured":"Schnell, P. O. et al. Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J. Neurochem. 85, 483\u2013491 (2003).","journal-title":"J. Neurochem."},{"key":"63324_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.28544","volume":"36","author":"J Burtscher","year":"2021","unstructured":"Burtscher, J., Syed, M. M. K., Lashuel, H. A. & Millet, G. P. Hypoxia conditioning as a promising therapeutic target in Parkinson\u2019s disease?. Mov. Disord. 36, 857\u2013861 (2021).","journal-title":"Mov. Disord."},{"key":"63324_CR12","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2174\/092986711797200426","volume":"18","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z., Yan, J., Chang, Y., Yan, S. S. D. & Shi, H. Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr. Med. Chem. 18, 4335\u20134343 (2011).","journal-title":"Curr. Med. Chem."},{"key":"63324_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aad9642","volume":"352","author":"IH Jain","year":"2016","unstructured":"Jain, I. H. et al. Hypoxia as a therapy for mitochondrial disease. Science 352, 54\u201361 (2016).","journal-title":"Science"},{"key":"63324_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.03.015","volume":"295","author":"M Smeyne","year":"2015","unstructured":"Smeyne, M., Sladen, P., Jiao, Y., Dragatsis, I. & Smeyne, R. J. HIF1alpha is necessary for exercise-induced neuroprotection while HIF2alpha is needed for dopaminergic neuron survival in the substantia nigra pars compacta. Neuroscience 295, 23\u201338 (2015).","journal-title":"Neuroscience"},{"key":"63324_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.29688","volume":"39","author":"JM Janssen Daalen","year":"2024","unstructured":"Janssen Daalen, J. M. et al. The hypoxia response pathway: a potential intervention target in Parkinson\u2019s disease? Mov. Disord. 39, 273\u2013293 (2024).","journal-title":"Mov. Disord."},{"key":"63324_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang, A. E. & Espay, A. J. Disease modification in Parkinson\u2019s disease: current approaches, challenges, and future considerations. Mov. Disord. 33, 660\u2013677 (2018).","journal-title":"Mov. Disord."},{"key":"63324_CR17","doi-asserted-by":"crossref","unstructured":"Burtscher, J. et al. Mechanisms underlying the health benefits of intermittent hypoxia conditioning. J. Physiol. 602, 5757\u20135783 (2023).","DOI":"10.1113\/JP285230"},{"key":"63324_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113891","volume":"347","author":"AK Vose","year":"2022","unstructured":"Vose, A. K. et al. Therapeutic acute intermittent hypoxia: a translational roadmap for spinal cord injury and neuromuscular disease. Exp. Neurol. 347, 113891 (2022).","journal-title":"Exp. Neurol."},{"key":"63324_CR19","doi-asserted-by":"crossref","unstructured":"Serebrovska, Z. O. et al. Intermittent hypoxia-hyperoxia training improves cognitive function and decreases circulating biomarkers of Alzheimer\u2019s disease in patients with mild cognitive impairment: a pilot study. Int. J. Mol. Sci. 20, 5405 (2019).","DOI":"10.3390\/ijms20215405"},{"key":"63324_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2012.02.003","volume":"18","author":"O Saeed","year":"2012","unstructured":"Saeed, O. et al. Improved exercise performance and skeletal muscle strength after simulated altitude exposure: a novel approach for patients with chronic heart failure. J. Card. Fail. 18, 387\u2013391 (2012).","journal-title":"J. Card. Fail."},{"key":"63324_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijcard.2003.07.021","volume":"96","author":"M Burtscher","year":"2004","unstructured":"Burtscher, M. et al. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. Int. J. Cardiol. 96, 247\u2013254 (2004).","journal-title":"Int. J. Cardiol."},{"key":"63324_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.resp.2008.10.012","volume":"165","author":"M Burtscher","year":"2009","unstructured":"Burtscher, M. et al. Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD. Respir. Physiol. Neurobiol. 165, 97\u2013103 (2009).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"63324_CR23","first-page":"114","volume":"3","author":"U Bayer","year":"2017","unstructured":"Bayer, U. et al. Intermittent hypoxic-hyperoxic training on cognitive performance in geriatric patients. Alzheimers Dement 3, 114\u2013122 (2017).","journal-title":"Alzheimers Dement"},{"key":"63324_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00007256-200939020-00002","volume":"39","author":"DL Bonetti","year":"2009","unstructured":"Bonetti, D. L. & Hopkins, W. G. Sea-level exercise performance following adaptation to hypoxia: a meta-analysis. Sports Med. 39, 107\u2013127 (2009).","journal-title":"Sports Med."},{"key":"63324_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000029507","volume":"67","author":"TV Serebrovskaya","year":"2000","unstructured":"Serebrovskaya, T. V. et al. Geriatric men at altitude: hypoxic ventilatory sensitivity and blood dopamine changes. Respiration 67, 253\u2013260 (2000).","journal-title":"Respiration"},{"key":"63324_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12877-019-1184-1","volume":"19","author":"U Bayer","year":"2019","unstructured":"Bayer, U. et al. Effects of intermittent hypoxia-hyperoxia on mobility and perceived health in geriatric patients performing a multimodal training intervention: a randomized controlled trial. BMC Geriatr. 19, 167 (2019).","journal-title":"BMC Geriatr."},{"key":"63324_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113483","volume":"335","author":"L Christiansen","year":"2021","unstructured":"Christiansen, L. et al. Acute intermittent hypoxia boosts spinal plasticity in humans with tetraplegia. Exp. Neurol. 335, 113483 (2021).","journal-title":"Exp. Neurol."},{"key":"63324_CR28","doi-asserted-by":"publisher","first-page":"919343","DOI":"10.3389\/fnagi.2022.919343","volume":"14","author":"M Guo","year":"2022","unstructured":"Guo, M., Ji, X. & Liu, J. Hypoxia and alpha-synuclein: inextricable link underlying the pathologic progression of Parkinson\u2019s disease. Front. Aging Neurosci. 14, 919343 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"63324_CR29","doi-asserted-by":"publisher","first-page":"101343","DOI":"10.1016\/j.arr.2021.101343","volume":"68","author":"J Burtscher","year":"2021","unstructured":"Burtscher, J., Mallet, R. T., Burtscher, M. & Millet, G. P. Hypoxia and brain aging: neurodegeneration or neuroprotection? Ageing Res. Rev. 68, 101343 (2021).","journal-title":"Ageing Res. Rev."},{"key":"63324_CR30","doi-asserted-by":"publisher","first-page":"105885","DOI":"10.1016\/j.parkreldis.2023.105885","volume":"118","author":"CA Kalva-Filho","year":"2024","unstructured":"Kalva-Filho, C. A., Faria, M. H., Papoti, M. & Barbieri, F. A. Acute and cumulative effects of hypoxia exposure in people with Parkinson\u2019s disease: a scoping review and evidence map. Park. Relat. Disord. 118, 105885 (2024).","journal-title":"Park. Relat. Disord."},{"key":"63324_CR31","unstructured":"Janssen Daalen, J. M. et al. Hypoxic conditioning in Parkinson\u2019s disease: randomized controlled multiple N-of-1 trials. https:\/\/github.com\/Federica-Giardina\/Talisman (2025)."},{"key":"63324_CR32","doi-asserted-by":"crossref","unstructured":"Janssen Daalen, J. M. et al. Respiratory dysfunction and abnormal hypoxic ventilatory response in mild to moderate Parkinson\u2019s disease. Mov. Disord. Clin. Pract. 11, 1550\u20131558 (2024).","DOI":"10.1002\/mdc3.14249"},{"key":"63324_CR33","doi-asserted-by":"publisher","first-page":"H216","DOI":"10.1152\/ajpheart.00060.2018","volume":"315","author":"RT Mallet","year":"2018","unstructured":"Mallet, R. T., Manukhina, E. B., Ruelas, S. S., Caffrey, J. L. & Downey, H. F. Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential. Am. J. Physiol. Heart Circ. Physiol. 315, H216\u2013h232 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"63324_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/1535370216649060","volume":"241","author":"EB Manukhina","year":"2016","unstructured":"Manukhina, E. B., Downey, H. F., Shi, X. & Mallet, R. T. Intermittent hypoxia training protects cerebrovascular function in Alzheimer\u2019s disease. Exp. Biol. Med. 241, 1351\u20131363 (2016).","journal-title":"Exp. Biol. Med."},{"key":"63324_CR35","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","volume":"368","author":"P Bartsch","year":"2013","unstructured":"Bartsch, P. & Swenson, E. R. Clinical practice: acute high-altitude illnesses. N. Engl. J. Med. 368, 2294\u20132302 (2013).","journal-title":"N. Engl. J. Med."},{"key":"63324_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/clc.22670","volume":"40","author":"O Glazachev","year":"2017","unstructured":"Glazachev, O., Kopylov, P., Susta, D., Dudnik, E. & Zagaynaya, E. Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study. Clin. Cardiol. 40, 370\u2013376 (2017).","journal-title":"Clin. Cardiol."},{"key":"63324_CR37","unstructured":"Kolesnikova, E. E. & Serebrovskaya, T. V. Parkinson\u2019s Disease and Intermittent Hypoxia Training (Nova Science Publishers, Inc., 2009)."},{"key":"63324_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0928-4680(98)81208-X","volume":"5","author":"T Serebrovskaya","year":"1998","unstructured":"Serebrovskaya, T. et al. Intermittent hypoxia (IH) improves hypoxic ventilatory sensitivity and blood dopamine (DA) in patients with Parkinson\u2019s disease (PD). Pathophysiology 5, 234\u2013234 (1998).","journal-title":"Pathophysiology"},{"key":"63324_CR39","doi-asserted-by":"publisher","first-page":"R1181","DOI":"10.1152\/ajpregu.00208.2014","volume":"307","author":"A Navarrete-Opazo","year":"2014","unstructured":"Navarrete-Opazo, A. & Mitchell, G. S. Therapeutic potential of intermittent hypoxia: a matter of dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1181\u2013R1197 (2014).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"63324_CR40","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Intermittent hypoxia training for treating mild cognitive impairment: a pilot study. Am. J. Alzheimers Dis. Other. Demen. 35, 1533317519896725 (2020).","DOI":"10.1177\/1533317519896725"},{"key":"63324_CR41","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/1535370217712691","volume":"242","author":"S Baillieul","year":"2017","unstructured":"Baillieul, S. et al. Hypoxic conditioning and the central nervous system: a new therapeutic opportunity for brain and spinal cord injuries?. Exp. Biol. Med. 242, 1198\u20131206 (2017).","journal-title":"Exp. Biol. Med."},{"key":"63324_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fnins.2015.00388","volume":"9","author":"E Rybnikova","year":"2015","unstructured":"Rybnikova, E. & Samoilov, M. Current insights into the molecular mechanisms of hypoxic pre- and postconditioning using hypobaric hypoxia. Front. Neurosci. 9, 388 (2015).","journal-title":"Front. Neurosci."},{"key":"63324_CR43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00421-019-04096-8","volume":"119","author":"A Torpel","year":"2019","unstructured":"Torpel, A., Peter, B., Hamacher, D. & Schega, L. Dose-response relationship of intermittent normobaric hypoxia to stimulate erythropoietin in the context of health promotion in young and old people. Eur. J. Appl. Physiol. 119, 1065\u20131074 (2019).","journal-title":"Eur. J. Appl. Physiol."},{"key":"63324_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1152\/japplphysiol.00564.2014","volume":"118","author":"JH Mateika","year":"2015","unstructured":"Mateika, J. H., El-Chami, M., Shaheen, D. & Ivers, B. Intermittent hypoxia: a low-risk research tool with therapeutic value in humans. J. Appl. Physiol. 118, 520\u2013532 (2015).","journal-title":"J. Appl. Physiol."},{"key":"63324_CR45","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jcp.21537","volume":"217","author":"G Yuan","year":"2008","unstructured":"Yuan, G., Nanduri, J., Khan, S., Semenza, G. L. & Prabhakar, N. R. Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J. Cell Physiol. 217, 674\u2013685 (2008).","journal-title":"J. Cell Physiol."},{"key":"63324_CR46","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.27505","volume":"33","author":"A Tosserams","year":"2018","unstructured":"Tosserams, A. et al. Underrepresentation of women in Parkinson\u2019s disease trials. Mov. Disord. 33, 1825\u20131826 (2018).","journal-title":"Mov. Disord."},{"key":"63324_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma, C. A. et al. Gender differences in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 819\u2013824 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"63324_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109548","volume":"36","author":"L Fernandez Garcia-Agudo","year":"2021","unstructured":"Fernandez Garcia-Agudo, L. et al. Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus. Cell Rep. 36, 109548 (2021).","journal-title":"Cell Rep."},{"key":"63324_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/ejn.14102","volume":"49","author":"G Paul","year":"2019","unstructured":"Paul, G. & Sullivan, A. M. Trophic factors for Parkinson\u2019s disease: where are we and where do we go from here?. Eur. J. Neurosci. 49, 440\u2013452 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"63324_CR50","doi-asserted-by":"publisher","first-page":"890509","DOI":"10.3389\/fnagi.2022.890509","volume":"14","author":"D Li","year":"2022","unstructured":"Li, D., Huang, L. T., Zhang, C. P., Li, Q. & Wang, J. H. Insights into the role of platelet-derived growth factors: implications for Parkinson\u2019s disease pathogenesis and treatment. Front. Aging Neurosci. 14, 890509 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"63324_CR51","doi-asserted-by":"crossref","unstructured":"Leston Pinilla, L., Ugun-Klusek, A., Rutella, S. & De Girolamo, L. A. Hypoxia signaling in Parkinson\u2019s disease: there is use in asking \u201cWhat HIF?\u201d. Biology 10, 723 (2021).","DOI":"10.3390\/biology10080723"},{"key":"63324_CR52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0306-4522(98)00593-4","volume":"90","author":"M Ohno","year":"1999","unstructured":"Ohno, M. et al. Expression of platelet-derived growth factor B-chain and beta-receptor in hypoxic\/ischemic encephalopathy of neonatal rats. Neuroscience 90, 643\u2013651 (1999).","journal-title":"Neuroscience"},{"key":"63324_CR53","doi-asserted-by":"crossref","unstructured":"Nagel, M. J., Jarrard, C. P. & Lalande, S. Effect of a Single session of intermittent hypoxia on erythropoietin and oxygen-carrying capacity. Int. J. Environ. Res. Public Health 17, 7257 (2020).","DOI":"10.3390\/ijerph17197257"},{"key":"63324_CR54","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1152\/japplphysiol.00941.2020","volume":"130","author":"F Wojan","year":"2021","unstructured":"Wojan, F., Stray-Gundersen, S., Nagel, M. J. & Lalande, S. Short exposure to intermittent hypoxia increases erythropoietin levels in healthy individuals. J. Appl. Physiol. 130, 1955\u20131960 (2021).","journal-title":"J. Appl. Physiol."},{"key":"63324_CR55","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1016\/j.wneu.2018.02.059","volume":"113","author":"H Tan","year":"2018","unstructured":"Tan, H. et al. The effects of intermittent whole-body hypoxic preconditioning on patients with carotid artery stenosis. World Neurosurg. 113, e471\u2013e479 (2018).","journal-title":"World Neurosurg."},{"key":"63324_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/BF02337729","volume":"74","author":"T Klausen","year":"1996","unstructured":"Klausen, T. et al. Human erythropoietin response to hypocapnic hypoxia, normocapnic hypoxia, and hypocapnic normoxia. Eur. J. Appl. Physiol. Occup. Physiol. 74, 475\u2013480 (1996).","journal-title":"Eur. J. Appl. Physiol. Occup. Physiol."},{"key":"63324_CR57","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1183\/09031936.00156009","volume":"37","author":"JV Brugniaux","year":"2011","unstructured":"Brugniaux, J. V. et al. Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans. Eur. Respir. J. 37, 880\u2013887 (2011).","journal-title":"Eur. Respir. J."},{"key":"63324_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1254\/jphs.09102FP","volume":"110","author":"S Tsunekawa","year":"2009","unstructured":"Tsunekawa, S., Ohi, Y., Ishii, Y., Sasahara, M. & Haji, A. Hypoxic ventilatory response in platelet-derived growth factor receptor-beta-knockout mice. J. Pharm. Sci. 110, 270\u2013275 (2009).","journal-title":"J. Pharm. Sci."},{"key":"63324_CR59","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1096\/fj.02-1111fje","volume":"17","author":"SXL Zhang","year":"2003","unstructured":"Zhang, S. X. L. et al. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B\/PDGF-beta receptor\/phosphatidylinositol 3-kinase\/Akt signaling in RN46A neuronal cells. FASEB J. 17, 1709 (2003).","journal-title":"FASEB J."},{"key":"63324_CR60","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.steroids.2005.05.003","volume":"70","author":"O Coste","year":"2005","unstructured":"Coste, O., Beers, P., Bogdan, A., Charbuy, H. & Touitou, Y. Hypoxic alteration of cortisol circadian rhythm in man after simulation of a long duration flight. Steroids 70, 803\u2013810 (2005).","journal-title":"Steroids"},{"key":"63324_CR61","doi-asserted-by":"publisher","first-page":"R1685","DOI":"10.1152\/ajpregu.00484.2010","volume":"299","author":"JP Richalet","year":"2010","unstructured":"Richalet, J. P., Letournel, M. & Souberbielle, J. C. Effects of high-altitude hypoxia on the hormonal response to hypothalamic factors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1685\u2013R1692 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"63324_CR62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00421324","volume":"45","author":"E Humpeler","year":"1980","unstructured":"Humpeler, E., Skrabal, F. & Bartsch, G. Influence of exposure to moderate altitude on the plasma concentraton of cortisol, aldosterone, renin, testosterone, and gonadotropins. Eur. J. Appl. Physiol. Occup. Physiol. 45, 167\u2013176 (1980).","journal-title":"Eur. J. Appl. Physiol. Occup. Physiol."},{"key":"63324_CR63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","volume":"5","author":"C Delaville","year":"2011","unstructured":"Delaville, C., Deurwaerdere, P. D. & Benazzouz, A. Noradrenaline and Parkinson\u2019s disease. Front. Syst. Neurosci. 5, 31 (2011).","journal-title":"Front. Syst. Neurosci."},{"key":"63324_CR64","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/WNR.0000000000001239","volume":"30","author":"MR Halliday","year":"2019","unstructured":"Halliday, M. R., Abeydeera, D., Lundquist, A. J., Petzinger, G. M. & Jakowec, M. W. Intensive treadmill exercise increases expression of hypoxia-inducible factor 1alpha and its downstream transcript targets: a potential role in neuroplasticity. Neuroreport 30, 619\u2013627 (2019).","journal-title":"Neuroreport"},{"key":"63324_CR65","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1249\/mss.0b013e31802f04c7","volume":"39","author":"LT Ferris","year":"2007","unstructured":"Ferris, L. T., Williams, J. S. & Shen, C. L. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med. Sci. Sports Exerc. 39, 728\u2013734 (2007).","journal-title":"Med. Sci. Sports Exerc."},{"key":"63324_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39811-9","volume":"14","author":"T Hao","year":"2023","unstructured":"Hao, T. et al. Hypoxia-reprogramed megamitochondrion contacts and engulfs lysosome to mediate mitochondrial self-digestion. Nat. Commun. 14, 4105 (2023).","journal-title":"Nat. Commun."},{"key":"63324_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-024-00664-8","volume":"10","author":"N Che","year":"2024","unstructured":"Che, N. et al. Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease. NPJ Parkinsons Dis. 10, 48 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"63324_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","volume":"9","author":"Y Tang","year":"2023","unstructured":"Tang, Y. et al. Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinsons Dis. 9, 23 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"63324_CR69","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s12028-024-01998-0","volume":"41","author":"E Andersson","year":"2024","unstructured":"Andersson, E. et al. Acute-phase neurofilament light and glial fibrillary acidic proteins in cerebrospinal fluid predict long-term outcome after severe traumatic brain injury. Neurocrit Care 41, 813\u2013827 (2024).","journal-title":"Neurocrit Care"},{"key":"63324_CR70","doi-asserted-by":"crossref","unstructured":"Trung Nguyen, K. et al. Changes in the levels of serum glial fibrillary acidic protein and the correlation with outcomes in severe traumatic brain injury patients. SAGE Open Med. 12, 20503121241260006 (2024).","DOI":"10.1177\/20503121241260006"},{"key":"63324_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02770-7","volume":"22","author":"JM Janssen Daalen","year":"2022","unstructured":"Janssen Daalen, J. M. et al. Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson\u2019s disease: study rationale and protocol. BMC Neurol. 22, 262 (2022).","journal-title":"BMC Neurol."},{"key":"63324_CR72","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1001\/jama.2018.18020","volume":"320","author":"BC Stunnenberg","year":"2018","unstructured":"Stunnenberg, B. C. et al. Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials. JAMA 320, 2344\u20132353 (2018).","journal-title":"JAMA"},{"key":"63324_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-104","volume":"13","author":"SA Billingham","year":"2013","unstructured":"Billingham, S. A., Whitehead, A. L. & Julious, S. A. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med. Res. Methodol. 13, 104 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"63324_CR74","doi-asserted-by":"publisher","first-page":"570472","DOI":"10.3389\/fphys.2020.570472","volume":"11","author":"J Soo","year":"2020","unstructured":"Soo, J., Girard, O., Ihsan, M. & Fairchild, T. The use of the SpO(2) to FiO(2) ratio to individualize the hypoxic dose in sport science, exercise, and health settings. Front. Physiol. 11, 570472 (2020).","journal-title":"Front. Physiol."},{"key":"63324_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15407\/fz62.03.078","volume":"62","author":"TV Serebrovska","year":"2016","unstructured":"Serebrovska, T. V., Serebrovska, Z. O. & Egorov, E. Fitness and therapeutic potential of intermittent hypoxia training: a matter of dose. Fiziol. Zh. 62, 78\u201391 (2016).","journal-title":"Fiziol. Zh."},{"key":"63324_CR76","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1580\/1080-6032(2000)011[0172:IVCHEO]2.3.CO;2","volume":"11","author":"N Garcia","year":"2000","unstructured":"Garcia, N., Hopkins, S. R. & Powell, F. L. Intermittent vs continuous hypoxia: effects on ventilation and erythropoiesis in humans. Wilderness Environ. Med. 11, 172\u2013179 (2000).","journal-title":"Wilderness Environ. Med."},{"key":"63324_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1469-7793.2000.00215.x","volume":"529","author":"TL Baker","year":"2000","unstructured":"Baker, T. L. & Mitchell, G. S. Episodic but not continuous hypoxia elicits long-term facilitation of phrenic motor output in rats. J. Physiol. 529, 215\u2013219 (2000).","journal-title":"J. Physiol."},{"key":"63324_CR78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1212\/01.WNL.0000437416.34298.43","volume":"82","author":"HB Hayes","year":"2014","unstructured":"Hayes, H. B. et al. Daily intermittent hypoxia enhances walking after chronic spinal cord injury: a randomized trial. Neurology 82, 104\u2013113 (2014).","journal-title":"Neurology"},{"key":"63324_CR79","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1055\/s-0030-1255067","volume":"31","author":"M Burtscher","year":"2010","unstructured":"Burtscher, M., Gatterer, H., Faulhaber, M., Gerstgrasser, W. & Schenk, K. Effects of intermittent hypoxia on running economy. Int J. Sports Med. 31, 644\u2013650 (2010).","journal-title":"Int J. Sports Med."},{"key":"63324_CR80","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fphys.2020.00531","volume":"11","author":"B Treml","year":"2020","unstructured":"Treml, B. et al. Carry-over quality of pre-acclimatization to altitude elicited by intermittent hypoxia: a participant-blinded, randomized controlled trial on antedated acclimatization to altitude. Front. Physiol. 11, 531 (2020).","journal-title":"Front. Physiol."},{"key":"63324_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1545968311412055","volume":"26","author":"RD Trumbower","year":"2012","unstructured":"Trumbower, R. D., Jayaraman, A., Mitchell, G. S. & Rymer, W. Z. Exposure to acute intermittent hypoxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabil. Neural Repair 26, 163\u2013172 (2012).","journal-title":"Neurorehabil. Neural Repair"},{"key":"63324_CR82","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1212\/WNL.0000000000004596","volume":"89","author":"RD Trumbower","year":"2017","unstructured":"Trumbower, R. D., Hayes, H. B., Mitchell, G. S., Wolf, S. L. & Stahl, V. A. Effects of acute intermittent hypoxia on hand use after spinal cord trauma: a preliminary study. Neurology 89, 1904\u20131907 (2017).","journal-title":"Neurology"},{"key":"63324_CR83","unstructured":"NCI. Common terminology criteria for adverse events (CTCAE) version 5.0. (2017)."},{"key":"63324_CR84","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","volume":"36","author":"DJ Bowen","year":"2009","unstructured":"Bowen, D. J. et al. How we design feasibility studies. Am. J. Prev. Med. 36, 452\u2013457 (2009).","journal-title":"Am. J. Prev. Med."},{"key":"63324_CR85","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1139\/y99-096","volume":"77","author":"TV Serebrovskaya","year":"1999","unstructured":"Serebrovskaya, T. V. et al. Human hypoxic ventilatory response with blood dopamine content under intermittent hypoxic training. Can. J. Physiol. Pharm. 77, 967\u2013973 (1999).","journal-title":"Can. J. Physiol. Pharm."},{"key":"63324_CR86","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1469-7793.2001.0509i.x","volume":"531","author":"AG Zabka","year":"2001","unstructured":"Zabka, A. G., Behan, M. & Mitchell, G. S. Long term facilitation of respiratory motor output decreases with age in male rats. J. Physiol. 531, 509\u2013514 (2001).","journal-title":"J. Physiol."},{"key":"63324_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2019.05.012","volume":"1719","author":"LL Xiong","year":"2019","unstructured":"Xiong, L. L. et al. Suppression of PDGF induces neuronal apoptosis after neonatal cerebral hypoxia and ischemia by inhibiting P-PI3K and P-AKT signaling pathways. Brain Res. 1719, 77\u201388 (2019).","journal-title":"Brain Res."},{"key":"63324_CR88","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yjmcc.2014.01.006","volume":"68","author":"M Helan","year":"2014","unstructured":"Helan, M. et al. BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia. J. Mol. Cell Cardiol. 68, 89\u201397 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"63324_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2012.01.017","volume":"206","author":"A Vermehren-Schmaedick","year":"2012","unstructured":"Vermehren-Schmaedick, A., Jenkins, V. K., Knopp, S. J., Balkowiec, A. & Bissonnette, J. M. Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice. Neuroscience 206, 1\u20136 (2012).","journal-title":"Neuroscience"},{"key":"63324_CR90","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","volume":"29","author":"Y Wang","year":"2016","unstructured":"Wang, Y., Liu, H., Zhang, B. S., Soares, J. C. & Zhang, X. Y. Low BDNF is associated with cognitive impairments in patients with Parkinson\u2019s disease. Park. Relat. Disord. 29, 66\u201371 (2016).","journal-title":"Park. Relat. Disord."},{"key":"63324_CR91","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00415-020-10299-3","volume":"268","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Huang, C., Zhang, Q., Wu, W. & Sun, J. Serum BDNF discriminates Parkinson\u2019s disease patients with depression from without depression and reflect motor severity and gender differences. J. Neurol. 268, 1411\u20131418 (2021).","journal-title":"J. Neurol."},{"key":"63324_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia, R. et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J. Neurotrauma 31, 19\u201325 (2014).","journal-title":"J. Neurotrauma"},{"key":"63324_CR93","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","volume":"93","author":"CH Lin","year":"2019","unstructured":"Lin, C. H. et al. Blood NfL: a biomarker for disease severity and progression in Parkinson disease. Neurology 93, e1104\u2013e1111 (2019).","journal-title":"Neurology"},{"key":"63324_CR94","doi-asserted-by":"publisher","first-page":"959261","DOI":"10.3389\/fnins.2022.959261","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Dou, K., Xue, L., Li, X. & Xie, A. Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease. Front. Neurosci. 16, 959261 (2022).","journal-title":"Front. Neurosci."},{"key":"63324_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03120-1","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: a prospective cohort study. BMC Med. 21, 420 (2023).","journal-title":"BMC Med."},{"key":"63324_CR96","doi-asserted-by":"crossref","unstructured":"Joisten, N. et al. Exercise diminishes plasma neurofilament light chain and reroutes the kynurenine pathway in multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 8, e982 (2021).","DOI":"10.1212\/NXI.0000000000000982"},{"key":"63324_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroscience.2018.11.040","volume":"398","author":"T Macheda","year":"2019","unstructured":"Macheda, T. et al. Chronic intermittent hypoxia induces robust astrogliosis in an Alzheimer\u2019s disease-relevant mouse model. Neuroscience 398, 55\u201363 (2019).","journal-title":"Neuroscience"},{"key":"63324_CR98","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/lio2.683","volume":"6","author":"B Arslan","year":"2021","unstructured":"Arslan, B., Semsi, R., Iriz, A. & Sepici Dincel, A. The evaluation of serum brain-derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome. Laryngoscope Investig. Otolaryngol. 6, 1466\u20131473 (2021).","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"63324_CR99","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1001\/jama.2018.17977","volume":"320","author":"AE McGlothlin","year":"2018","unstructured":"McGlothlin, A. E. & Viele, K. Bayesian hierarchical models. Jama 320, 2365\u20132366 (2018).","journal-title":"Jama"},{"key":"63324_CR100","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.parkreldis.2015.10.006","volume":"21","author":"K Horvath","year":"2015","unstructured":"Horvath, K. et al. Minimal clinically important difference on the Motor Examination part of MDS-UPDRS. Park. Relat. Disord. 21, 1421\u20131426 (2015).","journal-title":"Park. Relat. Disord."},{"key":"63324_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2522\/ptj.20120171","volume":"93","author":"M Godi","year":"2013","unstructured":"Godi, M. et al. Comparison of reliability, validity, and responsiveness of the mini-BESTest and Berg Balance Scale in patients with balance disorders. Phys. Ther. 93, 158\u2013167 (2013).","journal-title":"Phys. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63324-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63324-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63324-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:03:30Z","timestamp":1758891810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63324-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63324"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63324-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bastiaan R. Bloem has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, UCB, and Walk with Path; has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial; and has received research support from The Netherlands Organisation for Scientific Research, the Michael J. Fox Foundation, UCB, Abbvie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, and the Parkinson Vereniging. The other authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8469"}}